Diurnal, seasonal, and blood-processing patterns in levels of circulating fibrinogen, fibrin D-dimer, C-reactive protein, tissue plasminogen activator, and von Willebrand factor in a 45-year-old population

Circulation

Volumn 115, Issue 8, 2007, Pages 996-1003

  Rudnicka, Alicja R ^a   Rumley, Ann ^b   Lowe, Gordon D O ^b   Strachan, David P ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Coagulation; Fibrin; Fibrinogen; Plasminogen activators; Seasons; Von Willebrand factor

Indexed keywords

C REACTIVE PROTEIN; D DIMER; FIBRINOGEN; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BLOOD EXAMINATION; BLOOD SAMPLING; CARDIOVASCULAR RISK; CIRCADIAN RHYTHM; CIRCULATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GROUPS BY AGE; HOUSEHOLD; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SEASONAL VARIATION; STANDARD; STATISTICAL SIGNIFICANCE; UPREGULATION;

BLOOD SPECIMEN COLLECTION; C-REACTIVE PROTEIN; CIRCADIAN RHYTHM; CROSS-SECTIONAL STUDIES; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; HUMANS; MALE; MIDDLE AGED; SEASONS; SEX CHARACTERISTICS; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

EID: 33847307630     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.106.635169     Document Type: Article

References (42)

1. Fibrinogen Studies Collaboration. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA. 2005;294:1799-1809.
2. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Rumley A, Lowe GD. Fibrin D-dimer and coronary heart disease: prospective study and meta-analysis. Circulation. 2001;103:2323-2327.
3. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GD, Pepys MB, Gudnason V. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004;350:1387-1397.
4. Whincup PH, Danesh J, Walker M, Lennon L, Thomson A, Appleby P, Rumley A, Lowe GD. von Willebrand factor and coronary heart disease: prospective study and meta-analysis. Eur Heart J. 2002;23:1764-1770.
5. Lowe GD, Danesh J, Lewington S, Walker M, Lennon L, Thomson A, Rumley A, Whincup PH. Tissue plasminogen activator antigen and coronary heart disease: prospective study and meta-analysis. Eur Heart J. 2004;25:252-259.
6. Stout RW, Crawford V. Seasonal variations in fibrinogen concentrations among elderly people. Lancet. 1991;338:9-13.
7. Woodhouse PR, Khaw KT, Plummer M, Foley A, Meade TW. Seasonal variations of plasma fibrinogen and factor VII activity in the elderly: winter infections and death from cardiovascular disease. Lancet. 1994;343:435-439.
8. van der Bom JG, de Maat MP, Bots ML, Hofman A, Kluft C, Grobbee DE. Seasonal variation in fibrinogen in the Rotterdam Study. Thromb Haemost. 1997;78:1059-1062.
9. Frohlich M, Sund M, Russ S, Hoffmeister A, Fischer HG, Hombach V, Koenig W. Seasonal variations of rheological and hemostatic parameters and acute-phase reactants in young, healthy subjects. Arterioscler Thromb Vasc Biol. 1997;17:2692-2697.
10. Pitsavos C, Skoumas J, Dernellis J, Toutouza M, Doulalas A, Stefanadis C, Toutouzas P. Influence of biological factors on lipid and fibrinogen measurements in young men: an epidemiological study in 2009 recruits. Eur Heart J. 1998;19:1642-1647.
11. Crawford VL, Sweeney O, Coyle PV, Halliday IM, Stout RW. The relationship between elevated fibrinogen and markers of infection: a comparison of seasonal cycles. QJM. 2000;93:745-750.
12. Mavri A, Guzic-Salobir B, Salobir-Pajnic B, Keber I, Stare J, Stegnar M. Seasonal variation of some metabolic and haemostatic risk factors in subjects with and without coronary artery disease. Blood Coagul Fibrinolysis. 2001;12:359-365.
13. Assanelli D, Ferrari R, Iacoviello L, Di Castelnuovo A, Galeazzi GL, Boldini A, Albertini F, Maccalli P, Brentana L, Ascari L. Plasma fibrinogen variability in healthy citizens. Thromb Res. 2002;108:287-289.
14. Hermida RC, Calvo C, Ayala DE, Lopez JE, Fernandez JR, Mojon A, Dominguez MJ, Covelo M. Seasonal variation of fibrinogen in dipper and nondipper hypertensive patients. Circulation. 2003;108:1101-1106.
15. Crawford VL, McNerlan SE, Stout RW. Seasonal changes in platelets, fibrinogen and factor VII in elderly people. Age Ageing. 2003;32:661-665.
16. Stout RW, Crawford VL, McDermott MJ, Rocks MJ, Morris TC. Seasonal changes in haemostatic factors in young and elderly subjects. Age Ageing. 1996;25:256-258.
17. Otto C, Donner MG, Schwandt P, Richter WO. Seasonal variations of hemorheological and lipid parameters in middle-aged healthy subjects. Clin Chim Acta. 1996;256:87-94.
18. Folsom AR, Wu KK, Conlan MG, Finch A, Davis CE, Marcucci G, Sorlie PD, Szklo M. Distributions of hemostatic variables in blacks and whites: population reference values from the Atherosclerosis Risk in Communities (ARIC) Study. Ethn Dis. 1992;2:35-46.
19. Frohlich M, Sund M, Thorand B, Hutchinson WL, Pepys MB, Koenig W. Lack of seasonal variation in C-reactive protein. Clin Chem. 2002;48:575-577.
20. Horan JT, Francis CW, Falsey AR, Kolassa J, Smith BH, Hall WJ. Prothrombotic changes in hemostatic parameters and C-reactive protein in the elderly with winter acute respiratory tract infections. Thromb Haemost. 2001;85:245-249.
21. Macmillan AL, Corbett JL, Johnson RH, Smith AC, Spalding JM, Wollner L. Temperature regulation in survivors of accidental hypothermia of the elderly. Lancet. 1967;2:165-169.
22. Bremner WF, Sothern RB, Kanabrocki EL, Ryan M, McCormick JB, Dawson S, Connors ES, Rothschild R, Third JL, Vahed S, Nemchausky BM, Shirazi P, Olwin JH. Relation between circadian patterns in levels of circulating lipoprotein(a), fibrinogen, platelets, and related lipid variables in men. Am Heart J. 2000;139:164-173.
23. Pasqualetti P, Festuccia V, Acitelli P, Natali L, Collacciani A, Casale R. Circadian rhythms of fibrinogen antithrombin III and plasminogen in chronic liver diseases of increasing severity. Haemostasis. 1997;27:140-148.
24. Johansen LG, Gram J, Kluft C, Jespersen J. Chronobiology of coronary risk markers in Greenland Eskimos: a comparative study with Caucasians residing in the same Arctic area. Chronobiol Int. 1991;8:352-360.
25. Jafri SM, VanRollins M, Ozawa T, Mammen EF, Goldberg AD, Goldstein S. Circadian variation in platelet function in healthy volunteers. Am J Cardiol. 1992;69:951-954.
26. Iversen PO, Groot PD, Hjeltnes N, Andersen TO, Mowinckel MC, Sandset PM. Impaired circadian variations of haemostatic and fibrinolytic parameters in tetraplegia. Br J Haematol. 2002;119:1011-1016.
27. Angleton P, Chandler WL, Schmer G. Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1). Circulation. 1989;79:101-106.
28. van Diest R, Hamulyak K, Kop WJ, van Zandvoort C, Appels A. Diurnal variations in coagulation and fibrinolysis in vital exhaustion. Psychosom Med. 2002;64:787-792.
29. von Clauss A. Rapid physiological coagulation method in determination of fibrinogen. Acta Haematol. 1957;17:237-246.
30. Yarnell J, McCrum E, Rumley A, Patterson C, Salomaa V, Lowe G, Evans A. Association of European population levels of thrombotic and inflammatory factors with risk of coronary heart disease: the MONICA Optional Haemostasis Study. Eur Heart J. 2005;26:332-342.
31. Perdiz P, Wacher N, Laredo-Sanchez F, Halabe CJ, Lifshitz A. Circadian variation of human acute phase response. Arch Med Res. 1996;27:157-163.
32. Meier-Ewert HK, Ridker PM, Rifai N, Price N, Dinges DF, Mullington JM. Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects. Clin Chem. 2001;47:426-430.
33. Mercer JB, Osterud B, Tveita T. The effect of short-term cold exposure on risk factors for cardiovascular disease. Thromb Res. 1999;95:93-104.
34. Bridges AB, McLaren M, Saniabadi A, Fisher TC, Belch JJ. Circadian variation of endothelial cell function, red blood cell deformability and dehydro-thromboxane B2 in healthy volunteers. Blood Coagul Fibrinolysis. 1991;2:447-452.
35. Li-Saw-Hee FL, Blann AD, Lip GY. A cross-sectional and diurnal study of thrombogenesis among patients with chronic atrial fibrillation. J Am Coll Cardiol. 2000;35:1926-1931.
36. Lip GY, Edmunds E, Hee FL, Blann AD, Beevers DG. A cross-sectional, diurnal, and follow-up study of platelet activation and endothelial dysfunction in malignant phase hypertension. Am J Hypertens. 2001;14:823-828.
37. Rogowski O, Toker S, Shapira I, Melamed S, Shirom A, Zeltser D, Berliner S. Values of high-sensitivity C-reactive protein in each month of the year in apparently healthy individuals. Am J Cardiol. 2005;95:152-155.
38. Wannamethee SG, Lowe GD, Whincup PH, Rumley A, Walker M, Lennon L. Physical activity and hemostatic and inflammatory variables in elderly men. Circulation. 2002;105:1785-1790.
39. Booth NA, Anderson JA, Bennett B. Platelet release protein which inhibits plasminogen activators. J Clin Pathol. 1985;38:825-830.
40. Lippi G, Salvagno GL, Guidi GC. No influence of a butterfly device on routine coagulation assays and D-dimer measurement. J Thromb Haemost. 2005;3:389-391.
41. Lowe GD. Circulating inflammatory markers and risks of cardiovascular and non-cardiovascular disease. J Thromb Haemost. 2005;3:1618-1627.
42. Kushner I, Sehgal AR. Is high-sensitivity C-reactive protein an effective screening test for cardiovascular risk? Arch Intern Med. 2002;162:867-869.